Resultados de la búsqueda 111-120 de 3334 para anti-TNF drugs
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which ...
... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...
Page 1.
... treatment for patients with Stage I-III breast cancer. ... therapy can predict pathological Complete Response (pCR). ... The purpose of this study is to evaluate ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been treated ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?